Evidence map›Paper›PMID 40343043›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Calculating epidemiological outcomes from simulated longitudinal data.

Selina Pi, Jeremy D Goldhaber-Fiebert, Fernando Alarid-Escudero

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Selina PiDepartment of Biomedical Data Science, School of Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0002-9940-1925
Jeremy D Goldhaber-FiebertDepartment of Health Policy, School of Medicine, Center for Health Policy, Freeman-Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.ORCID 0000-0002-4007-5192
Fernando Alarid-EscuderoDepartment of Health Policy, School of Medicine, Center for Health Policy, Freeman-Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.ORCID 0000-0001-5076-1172

Funding

POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
Comparative Modeling of Effective Policies for Colorectal Cancer ControlU01CA253913 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI RUTTER, CAROLYN M, ZAUBER, ANN GRAHAM · 2020 to 2025
$6.5M
Population Modeling of Bladder Cancer Detection and ControlU01CA265750 · NCI · BROWN UNIVERSITY · PI JALAL, HAWRE, TRIKALINOS, THOMAS · 2021 to 2025
$3.4M
NCI NIH HHS U01 CA253913NCI NIH HHS U01 CA265750NLM NIH HHS T15 LM007033
6 · The paper itself

Abstract

Microsimulation models generate individual life trajectories that must be summarized as population-level outcomes for model calibration and validation. While there are established formulas to calculate outcomes such as prevalence, incidence, and lifetime risk from cross-sectional and short-term longitudinal studies, limited guidance exists to calculate these outcomes using long-term longitudinal data due to the rarity of large-scale studies covering events across the human lifespan. This technical report presents various methods to calculate epidemiological outcomes from simulated longitudinal data, from replicating a real-world study design to fully incorporating longitudinal disease and exposure durations. We provide an open-source code base with functions in R to calculate the prevalence, incidence, age-conditional risk, lifetime risk, and disease-specific mortality of a condition from individual-level time-to-event data. In addition, we provide guidance and code for calculating cancer-related outcomes from individual-level data, such as the stage distribution at diagnosis, the distribution of precancerous lesion multiplicity, and the mean dwell and sojourn time. Given the various possible formulations for certain outcomes, we call for increased transparency in reporting how summary outcomes are derived from microsimulation model outputs, and we anticipate that this report will facilitate the calculation of epidemiological outcomes in both simulated and real-world data.

Indexed as

epidemiologyincidencemicrosimulationprevalence

Identifiers

PMID40343043
PMCPMC12060962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.